retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial for diabetes type hormone receptor metabolic dysfunction-associated steatotic liver disease: a randomized 2a Retatrutide is gaining attention in – retatrutide clinical trial outcomes The – retatrutide triple agonist glp-1 gip

The 2025 joint advisory, ACLM/ASN/OMA/TOS names magnesium citrate specifically for GLP-1 constipation

GLP-1s have changed the landscape for obesity care, and people who take them should know what to expect with these treatments, as being prepared may help with long-term success, says Kimberly Gudzune, MD, MPH, a board-certified obesity medicine physician and affiliate faculty at the Johns Hopkins Bloomberg School of Public Health in Baltimore

Each component in this formula has its own health benefits and is low in side effects

Generic One of the biggest cost factors is whether youre getting a brand-name medication or a generic version